We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+14.14%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$94.3B
AUM Growth
+$7.96B
(+9.2%)
Cap. Flow
-$2.37B
Cap. Flow
% of AUM
-2.52%
Top 10 Holdings %
Top 10 Hldgs %
12.56%
Holding
2,315
New
140
Increased
934
Reduced
1,002
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$335M |
| 2 |
Exelon
EXC
|
+$314M |
| 3 |
Procter & Gamble
PG
|
+$241M |
| 4 |
TripAdvisor
TRIP
|
+$208M |
| 5 |
Starbucks
SBUX
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$551M |
| 2 |
Target
TGT
|
+$514M |
| 3 |
CELG
Celgene Corp
CELG
|
+$495M |
| 4 |
Cigna
CI
|
+$369M |
| 5 |
Costco
COST
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.77% |
| 2 | Healthcare | 19.09% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Industrials | 9.28% |
| 5 | Financials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RRD
951
DELISTED
RR Donnelley & Sons Co.
RRD
| $5.5M | 0.01% |
1,165,886
+746,845
| +178% | +$3.85M |
|
|
EGRX
952
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.45M | 0.01% |
107,954
+10,519
| +11% | +$468K |
|
953
Blackstone Mortgage Trust
BXMT
$2.39B
| $5.44M | 0.01% |
157,471
-4,033
| -2% | -$137K |
|
954
Neurocrine Biosciences
NBIX
$16.8B
| $5.43M | 0.01% |
61,648
-57,876
| -48% | -$4.84M |
|
|
TLRD
955
DELISTED
Tailored Brands, Inc.
TLRD
| $5.42M | 0.01% |
690,727
+372,459
| +117% | +$4.41M |
|
|
CHS
956
DELISTED
Chicos FAS, Inc.
CHS
| $5.4M | 0.01% |
1,264,379
-385,077
| -23% | -$2.13M |
|
|
DISH
957
DELISTED
DISH Network Corp.
DISH
| $5.38M | 0.01% |
169,696
-849,007
| -83% | -$26M |
|
958
Harmony Gold Mining
HMY
$12.4B
| $5.34M | 0.01% |
2,812,682
+1,576,301
| +127% | +$3.09M |
|
959
FirstEnergy
FE
$27.1B
| $5.32M | 0.01% |
128,211
-386,717
| -75% | -$15.4M |
|
960
America Movil
AMX
$71.7B
| $5.3M | 0.01% |
371,483
+5,572
| +2% | +$84.1K |
|
|
TIF
961
DELISTED
Tiffany & Co.
TIF
| $5.3M | 0.01% |
50,428
-158,964
| -76% | -$14.6M |
|
|
EXAS
962
DELISTED
Exact Sciences
EXAS
| $5.28M | 0.01% |
61,006
+45,118
| +284% | +$3.84M |
|
963
Cal-Maine
CALM
$3.85B
| $5.27M | 0.01% |
118,133
+41,762
| +55% | +$1.82M |
|
|
HF
964
DELISTED
HFF Inc.
HF
| $5.21M | 0.01% |
109,070
-37,407
| -26% | -$1.59M |
|
965
Independent Bank Corp
IBCP
$841M
| $5.2M | 0.01% |
241,896
-24,118
| -9% | -$542K |
|
966
PC Connection
CNXN
$2.08B
| $5.19M | 0.01% |
141,582
+47,985
| +51% | +$1.72M |
|
967
Varonis Systems
VRNS
$4.87B
| $5.19M | 0.01% |
260,931
-1,659
| -0.6% | -$31.5K |
|
968
BancFirst
BANF
$3.77B
| $5.18M | 0.01% |
99,338
-1,607
| -2% | -$87K |
|
|
CDR
969
DELISTED
Cedar Realty Trust, Inc
CDR
| $5.16M | 0.01% |
230,028
+122,810
| +115% | +$2.76M |
|
970
Selective Insurance
SIGI
$5.66B
| $5.16M | 0.01% |
81,561
-3,461
| -4% | -$218K |
|
971
Fomento Económico Mexicano
FMX
$40.9B
| $5.14M | 0.01% |
55,751
-8,058
| -13% | -$735K |
|
972
Cameco
CCJ
$42.4B
| $5.14M | 0.01% |
436,377
+314,229
| +257% | +$3.78M |
|
973
FirstCash
FCFS
$9.05B
| $5.14M | 0.01% |
59,430
-17,220
| -22% | -$1.44M |
|
|
MGLN
974
DELISTED
Magellan Health Services, Inc.
MGLN
| $5.13M | 0.01% |
77,825
-5,865
| -7% | -$376K |
|
975
RadNet
RDNT
$6.08B
| $5.13M | 0.01% |
413,622
-289,797
| -41% | -$3.8M |
|
Similar funds
VGA
AQR Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, AQR Capital Management held 2,315 positions worth $94.3B, up 9.2% from $86.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q1 2019 filing shows 140 new, 934 increased, 1,002 reduced and 155 closed positions. Its largest new stake was Canopy Growth: 121,700 shares worth $52.7M. The largest sale was Walmart Inc, an estimated $551M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AQR Capital Management's largest Q1 2019 buy was Canopy Growth: 121,700 shares worth $52.7M.
- AQR Capital Management added most to Biogen in Q1 2019, an estimated $335M increase.
- AQR Capital Management's biggest Q1 2019 reduction was Walmart Inc, cutting an estimated $551M.
- AQR Capital Management fully exited Dun & Bradstreet in Q1 2019, selling an estimated $74.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $94.3B portfolio in Q1 2019.
- AQR Capital Management opened 140 new positions and closed 155 in Q1 2019.
- AQR Capital Management's portfolio value rose 9.2% quarter-over-quarter to $94.3B.
Based on AQR Capital Management's 13F filing for Q1 2019, filed 14 May 2019.